Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | XDH | P47989 | 3/20 | 0.65 |
| ▸ | GDA | Q9Y2T3 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1767753 | 0.86 | XDH (0.66) | XDHGDA | |
| SCHEMBL29767333 | 0.86 | XDH (0.70) | XDHGDA | |
| SCHEMBL10421282 | 0.86 | XDH (0.70) | XDHGDA | |
| SCHEMBL874738 | 0.84 | XDH (0.74) | XDHGDA | |
| SCHEMBL5935074 | 0.83 | XDH (0.78) | XDHGDA | |
| SCHEMBL9960821 | 0.83 | XDH (0.69) | XDHGDA | |
| SCHEMBL2113442 | 0.82 | XDH (0.57) | XDHGDA | |
| SCHEMBL667798 | 0.81 | XDH (0.84) | XDHGDA | |
| SCHEMBL28721442 | 0.81 | XDH (0.74) | XDHGDA | |
| SCHEMBL7672467 | 0.81 | GDA (0.56) | XDHGDA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104749286-B | A kind of analyzing detecting method of valganciclovir hydrochloride impurity | 湖北丽益医药科技有限公司 | 2017-03-08 | — | — | CN | disclosed |
| CN-104749286-A | Valganciclovir hydrochloride impurity analytical detecting method | HUBEI LIVSCIEN PHARM SCI & TECH CO LTD | 2015-07-01 | — | — | CN | disclosed |
| CN-104749286-A | Valganciclovir hydrochloride impurity analytical detecting method | HUBEI LIVSCIEN PHARM SCI & TECH CO LTD | 2015-07-01 | — | — | CN | disclosed |
| US-20110207931-A1 | PREPARATION OF VALGANCICLOVIR AND ITS SALTS | DR. REDDY'S LABORATORIES LIMITED (IN) | 2011-08-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110207931-A1 | PREPARATION OF VALGANCICLOVIR AND ITS SALTS | TYMP, CYP3A7, CYP2C9 | XDH 871/4885GDA 236/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.